Paper 73 - OUTCOME OF PATIENTS WITH METASTATIC NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMAS ENROLLED ON ARST0332 CLINICAL TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP

Author(s)

• 

  Sapna Oberoi, MD, MSc

  Assistant Professor
  CancerCare Manitoba
  Winnipeg, Manitoba, Canada

  Slides

Co-Author(s)

• ZG

  Zhengya Gao, MS

  University of Florida
  Gainesville, Florida, United States
• WX

  Wei Xue, PhD

  University of Florida
  Gainesville, Florida, United States
• RR

  R Lor Randall, MD

  University of California Davis Comprehensive Cancer Center
  Sacramento, California, United States
• CC

  Cheryl M. Coffin, MD

  Vanderbilt University School of Medicine
  Nashville, Tennessee, United States
• LM

  Lynn Million, MD

  Stanford University School of Medicine
  Stanford, California, United States
• SW

  Suzanne Wolden, MD

  Memorial Sloan Cancer Center
  New York, New York, United States
• MM

  M. Beth McCarville, MD

  Vanderbilt University School of Medicine
  Nashville, Tennessee, United States
• SK

  Simon C. Kao, MD

  University of Iowa Carver College of Medicine
  Iowa City, Iowa, United States
• RV

  Rajkumar Venkatramani, MD

  Texas Children's Cancer Center
  Houston, Texas, United States
• SS

  Sheri L. Spunt, MD, BA

  Senior Medical Director
  ImmunoGen
  Boston, Massachusetts, United States
• 

  Aaron R. Weiss, DO

  Pediatric Hematology-Oncology
  Maine Medical Center
  Scarborough, Maine, United States